Arecor Therapeutics plc, the biopharmaceutical company advancing ’s therapies to enable healthier lives, announces the triggering of a milestone payment from its global pharmaceutical partner, following the first commercial sale of a product, AT220, incorporating its proprietary Arestat™ technology platform.
November 17, 2023
· 2 min read